Pharmafile Logo
Pharmafocus logo
Advanced Search

Newly created Sanofi-Aventis buoyed by Acomplia

September 2, 2004

The merger of Sanofi-Synthelabo and Aventis to form the world's third biggest pharmaceutical company has been completed, and has coincided …

News

Revolutionary Zocor Heart Pro gets off to a flying start

September 2, 2004

News

The future of brand launches

September 1, 2004

After a chat with a few trusty friends over a beer and my tarot cards at the ready, here are …

Feature

OTC statins: lifesaver or lifestyle?

September 1, 2004

Feature

Parexel forms clinical trial partnership with Doctors.net.uk

September 1, 2004

Leading US-based contract research organisation Parexel has formed an exclusive partnership with online medical community Doctors.net.uk, to expand its UK …

News

Sykes opens Chiltern’s new global headquarters

September 1, 2004

Leading independent clinical research organisation (CRO) Chiltern International has opened its new global headquarters in Slough.Guest of honour Sir Richard …

News

Online prescriptions given go-ahead as part of reforms

September 1, 2004

The opening of online pharmacies has been given the go-ahead by the UK government, signalling the latest phase of a …

News

No food or drink restrictions for new HIV treatment

September 1, 2004

GlaxoSmithKline has launched Telzir in the UK, a new protease inhibitor for HIV patients and the first ever to have …

News

GSK settles US antidepressant lawsuit with $2.5 million

September 1, 2004

GlaxoSmithKline has paid $2.5 million to the State of New York in an out-of-court settlement of the lawsuit alleging it …

News

Alarm raised over counterfeit Cialis

August 26, 2004

Patients taking Cialis have been warned that counterfeit versions of the impotence drug are in circulation in the UK, the …

News

Cymbalta launched amid renewed controversy

August 26, 2004

Lilly has launched its new depression treatment Cymbalta in the US, a blockbuster tipped to earn $2 billion by 2008.Cymbalta …

News

Novartis claims Prexige safety advantage over rivals

August 26, 2004

Novartis is preparing its latest blockbuster candidate Prexige for launch around the world by proclaiming its superior side-effect profile to …

News

Industry welcomes broadening of hypertension treatment

August 26, 2004

News

Trust defends Alzheimer’s drug spending review

August 26, 2004

News

New technology in clinical trials

August 25, 2004

Feature

Harnessing the NHS agenda

August 23, 2004

Feature

New study highlights additional benefits of Aricept

August 20, 2004

News

Commission continues pursuit of AstraZeneca

August 19, 2004

News

Barker named new ABPI chief

August 12, 2004

Dr Richard Barker has been named as successor to Dr Trevor Jones as the ABPI's director general.Dr Jones, who has …

News

Novartis to ace competition in new hypertension class

August 12, 2004

Novartis is expected to take the lead in the newest class of hypertension treatments when it launches aliskiren in 2006.Analysts …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026